BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3415420)

  • 1. [Oxybutynin chloride in pediatrics: extenuating circumstances].
    Aubert D
    Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Instability of the detrusor muscle. Treatment with oxybutynin chloride (ditropan)].
    Perales Cabanas L; Tallada Buñuel M; Romero Maroto J; Escribano Patiño G
    Actas Urol Esp; 1986; 10(6):481-6. PubMed ID: 3825651
    [No Abstract]   [Full Text] [Related]  

  • 4. Terodiline and oxybutynin in detrusor instability.
    Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxybutynin chloride in the management of idiopathic detrusor instability.
    Paulson DF
    South Med J; 1979 Mar; 72(3):374-5. PubMed ID: 424842
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Schaefer W
    Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621
    [No Abstract]   [Full Text] [Related]  

  • 8. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Moore KH; Goldstein M; Hay D
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1063-4. PubMed ID: 2082973
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxybutynin and incontinence during grand mal seizures.
    Harari D; Malone-Lee JG
    Br J Urol; 1991 Dec; 68(6):658. PubMed ID: 1773301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuropsychiatric adverse effects attributed to use of oxybutynin].
    t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulant monitoring to assess the efficacy of oxybutynin chloride in patients with mixed incontinence.
    van Waalwijk van Doorn ES; Zwiers W
    Eur Urol; 1990; 18(1):49-51. PubMed ID: 2401307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study.
    Hooper P; Tincello DG; Richmond DH
    Br J Urol; 1997 Sep; 80(3):414-6. PubMed ID: 9313659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can oxybutynin cause peripheral neuropathy?
    Patel HR; Albehussi S; Arya M; Miller RA
    J Urol; 2002 Aug; 168(2):646. PubMed ID: 12131334
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of Ditropan in the elderly: nursing responsibilities.
    Anderson CL
    Perspectives; 1993; 17(3):11. PubMed ID: 8116314
    [No Abstract]   [Full Text] [Related]  

  • 16. Tethered cord syndrome in an adult. Pharmacological treatment of the urological symptomatology by oxybutynin.
    De Angelis M; Martina G; Caverni L; Coglitore A; Libanori GP; Giannotti P
    Acta Urol Belg; 1986; 54(1):99-105. PubMed ID: 3962800
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study.
    Zorzitto ML; Holliday PJ; Jewett MA; Herschorn S; Fernie GR
    Age Ageing; 1989 May; 18(3):195-200. PubMed ID: 2675580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxybutynin hydrochloride in the management of detrusor instability.
    Primus G; Pummer K
    Int Urol Nephrol; 1990; 22(3):243-8. PubMed ID: 2210980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose oxybutynin for the unstable bladder.
    Malone-Lee J; Lubel D; Szonyi G
    BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children].
    Aubert D; Cencig P; Royer M
    Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.